Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...
Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...
Morning Overview on MSN
Revolution Medicines trial points to longer survival in pancreatic cancer
For more than two decades, oncologists treating advanced pancreatic cancer have watched new drugs fail to move the survival ...
The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results